期刊文献+

检测循环内皮细胞评估晚期食管癌放化疗疗效的价值

Significance of detecting circulating endothelial cell in evaluating the efficacy of radiochemotherapy in patients with advanced esophageal cancer
原文传递
导出
摘要 目的探讨检测外周血循环内皮细胞(CEC)在晚期食管癌放化疗疗效评估中的价值。方法 66例晚期食管鳞癌患者分为化疗组(21例,用PF方案)、放疗组(18例,剂量60~70 Gy/6周)和放化疗联合组(27例)。用流式细胞术检测外周血CEC。结果晚期食管癌患者CEC基础值较健康者高[(20.84±7.31)个/μl vs.(11.14±3.07)个/μl](P〈0.01)。治疗前,3组CEC数相仿;治疗后,放化疗联合组CEC较治疗前显著降低[(14.39±5.36)个/μl vs.(20.22±7.01)个/μl](P〈0.01),其他两组降低不明显。结论检测治疗前外周血CEC有可能成为预测晚期食管癌患者放化疗疗效的指标。 Objective To investigate the significance of detecting circulating endothelial cell(CEC)in evaluating the efficacy of radiochemotherapy in the patients with advanced esophageal cancer.Methods Sixty-six patients with advanced esophageal cancer were divided into groups of chemotherapy(group A,21 cases,PF regimen),radiotherapy(group B,18 cases,60~70 Gy/6w) and chemoradiotherapy(group C,27 cases).The CECs were detected with flow cytometry.Results The CECs were higher in the patients with advanced esophageal cancer than those in the healthy people [(20.84±7.31) pieces/μl vs.(11.14±3.07) pieces/μl](P0.01).Before treatment,the CECs of three groups were similar.The CECs of group C were lower after treatment than those before [(14.39±5.36) pieces/μl vs.(20.22±7.01) pieces/μl](P0.01),which were not significantly decreased in groups of A and B.Conclusion Detection of CECs in periphyral blood could be taken as a marker in evaluating the efficacy of radiochemotherapy in the patients with advanced esophageal cancer.
出处 《江苏医药》 CAS CSCD 北大核心 2011年第7期792-794,共3页 Jiangsu Medical Journal
基金 江苏省"333工程"培养资金资助项目(苏人才办[2009]24号)
关键词 食管癌 循环内皮细胞 Esophageal cancer Circulating endothelial cell
  • 相关文献

参考文献7

  • 1Cooper JS, Guo MD, Herskovic A, et al. Chemoradiotherapy of locally advanced esophageal cancer: long term follow up of a prospective randomized trail (RTOG8501) : Radiation Therapy Oncology Group[J]. JAMA, 1999,281(17) : 1623-1627.
  • 2Beaudry P, Force J, Naumov NG, et al. Differential effects of vascular endothelial growth factor receptor-2 inhibitor ZD6474 on circulating endothelial progenitors and mature circulating endoyhelial cells: implications for use as surrogate marker of antiangiogenic activity[J]. Clin Cancer Res, 2005,11(9) : 3514.
  • 3Mancuso P, Burlini A, Pruneri G, et al. Resting and activatedendothelial cells are increased in periphareal blood of cancer patients[J]. Blood, 2001,97 (11) : 3658-3661.
  • 4Mancuso P, Colleoni M, Calleri A, et al. Circulating endothelial cell kinetics and viability predict survival in breast patients receiving metronomic chemotherapy[J]. Blood, 2006,108 (2) 452-459.
  • 5黄纯,李凯,魏熙胤,牛瑞芳,孙燕,王金万,朱允中,徐丽焱,刘晓晴,高红军,周静敏,王秀问.晚期非小细胞肺癌循环血管内皮细胞水平的研究[J].中华肿瘤杂志,2006,28(10):780-783. 被引量:27
  • 6Laura V, Astrid AM, Vander V, et al. Increased number of small circulating endothelial cells in renal cancer patients treated with sunitinib[J]. Angiogenesis, 2009,12 (1) : 69-79.
  • 7Bertolini F, Shaked Y, Mancuso P, et al. The multifaceted circulating endothelial cell in cancer: towards marker and target identification[J]. Nat Rev Cancer, 2006,6 (11) : 835-845.

二级参考文献16

  • 1徐建明,宋三泰.表皮生长因子受体酪氨酸激酶靶向药物与化疗联合应用的合理设计[J].中华肿瘤杂志,2004,26(6):321-323. 被引量:20
  • 2Folkman J.Angiogenesis in cancer,vascular,rheumatoid and other disease.Nat Med,1995,1:27-31.
  • 3O'Reilly MS,Bohem T,Shing Y,et al.Edostatin:an endogenous inhibitor of angiogenesis and tumor growth.Cell,1997,88:277-285.
  • 4Beaudry P,Force J,Naumov GN,et al.Differential effects of vascular endothelial growth factor receptor-2 inhibitor ZD6474 on circulating endothelial progenitors and mature circulating endothelial cells:implications for use as a surrogate marker of antiangiogenic activity.Clin Cancer Res,2005,11:3514-3522.
  • 5Ou-Yang F,Lan KL,Chen CT,et al.Endostatin-cytosine deaminase fusion protein suppresses tumor growth by targeting neovascular endothelial cells.Cancer Res,2006,66:378-384.
  • 6George F,Brouqui P,Boffa MC,et al.Demonstration of Rickettsia conorii-induced endothelial injury in vivo by measuring circulating endothelial cells,thrombomodulin,and von Willebrand factor in patients with Mediterranean spotted fever.Blood,1993,82:2109-2116.
  • 7Davidoff AM,Ng CY,Brown P,et al.Bone marrow-derived cells contribute to tumor neovasculature and,when modified to express an angiogenesis inhibitor,can restrict tumor growth in mice.Clin Cancer Res,2001,7:2870-2879.
  • 8Natori T,Sata M,Washida M,et al.G-CSF stimulates angiogenesis and promotes tumor growth:potential contribution of bone marrowderived endothelial progenitor cells.Bionhem Biophys Res Commun,2002,297:1058-1061.
  • 9Mancuso P,Burlini A,Pruneri G,et al.Resting and activated endothelial cells are increased in the peripheral blood of cancer patients.Blood,2001,97:3658-3661.
  • 10Monestiroli S,Mancuso P,Burlini A,et al.Kinetics and viability of circulating endothelial cells as surrogate angiogenesis marker in an animal model of human lymphoma.Cancer Res,2001,61:4341-4344.

共引文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部